Table 3 Data on patients with stage IIB-IV cervical cancer before and after matching
Variables | Unmatched | Matched | ||||
|---|---|---|---|---|---|---|
SCC (n = 4444) | AC/ASC (n = 174) | p-value | SCC (n = 690) | AC/ASC (n = 173) | p-value | |
Age (years) | 55.67 ± 10.78 | 55.34 ± 10.66 | 0.694 | 55.82 ± 11.24 | 55.49 ± 10.51 | 0.721 |
FIGO stage | 0.000 | 0.262 | ||||
IIB | 1845 (41.5%) | 67 (38.5%) | 308 (44.6%) | 67 (38.7%) | ||
III | 34 (0.8%) | 4 (2.3%) | 7 (1.0%) | 4 (2.3%) | ||
IIIA | 228 (5.1%) | 6 (3.5%) | 36 (5.2%) | 6 (3.5%) | ||
IIIB | 2142 (48.2%) | 78 (44.8%) | 295 (42.8%) | 78 (45.1%) | ||
IV | 61 (1.4%) | 3 (1.7%) | 10 (1.5%) | 3 (1.7%) | ||
IVA | 31 (0.7%) | 4 (2.3%) | 11 (1.6%) | 4 (2.3%) | ||
IVB | 103 (2.3%) | 12 (6.9%) | 23 (3.3%) | 11 (6.4%) | ||
Tumour size | 0.557 | 0.977 | ||||
> 4 cm | 2087 (47.0%) | 75 (43.1%) | 238 (34.5%) | 61 (35.3%) | ||
≤ 4 cm | 1429 (32.1%) | 62 (35.6%) | 305 (44.2%) | 75 (43.3%) | ||
Unknown | 928 (20.9%) | 37 (21.3%) | 147 (21.3%) | 37 (21.4%) | ||